Bahto Biosciences

Bahto Biosciences develops non-opioid small-molecule therapeutics for painful peripheral neuropathy, a condition with limited effective treatment options that afflicts more than 19 million Americans.

Bahto Biosciences

Location

United States

Extended description

Bahto Biosciences is a health and lifetech company focused on developing non-opioid small-molecule therapeutics for painful peripheral neuropathy, a condition with limited effective treatment options. The company utilizes a proprietary chemical scaffold to generate novel composition-of-matter derivatives that have demonstrated in vivo efficacy. Bahto Biosciences aims to advance its lead candidate toward investigational new drug-enabling studies, potentially delivering the first disease-modifying therapy for this challenging condition. Founded by experienced drug discovery experts with a strong track record in advancing multiple drugs to clinical trials and successful asset development, Bahto Biosciences contributes to innovation by addressing unmet medical needs through pioneering therapeutic approaches.

https://bahtobio.com/

Related industries

Lifetech
Health & Longevity

Stay connected

Sign up for our global newsletter